Investing.com - Financial Markets Worldwide
Get 40% Off
Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Biosergen AS (BIOSGN)

Stockholm
Currency in SEK
Disclaimer
0.31
-0.03(-9.06%)
Closed

BIOSGN Comments

https://news.cision.com/biosergen-ab/r/biosergen-successfully-completes-first-cohort-of-bsg005-phase-i-trial,c3564505
Biosergen’s CEO Peder M. Andersen comments:“This is very positive news and promising for the coming administrations of BSG005. First administration in Man is always the most exiting moment in any drug development program. That we with these first administrations have had no adverse event reports at all and nothing in the laboratory data is a promising result and is the best possible start of this phase I study. The study dose escalations are done very carefully and only after full review of each cohort data by the Safety Review Committee. The committee recommends the escalation to the next dose level and if the data we have seen now after the first dosings continue to come out like this, then BSG005 has come a long way on the travel to phase II and phase III and ultimately a Marketing Approval.We know this is early and few data however very
https://www.patientwing.com/study/383000?studySiteId=3202742&lang=en&showAdvancedDetails=true
looks great
This is going ro *******
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.